Cure pharmaceutical announces rob davidson as new chairman of the board and appointment of rob costantino as member of the board and audit committee chairman

Rob davidson brings a deep understanding of cure pipeline, provides expertise in continued new product development, patent creation and continuity in non-dilutive on-going deal transactions and years of public company experience.

CURR Ratings Summary

CURR Quant Ranking